North America Topical Corticosteroids Market – Industry Trends and Forecast to 2024

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

North America Topical Corticosteroids Market – Industry Trends and Forecast to 2024

North America
Publish Reports
North America Topical Corticosteroids Market
  • No of pages :
    350
  • No of Figures:
    60
  • No of Tables:
    220
  • Report Type:
    Publish
  • Category:

North America Corticosteroids Market By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Brands (Betnovate, Betnovate N, Panderm Plus, Lobate, Cosvate G, Clop G, Tenovate GN, Lobate GM, Ultiderm, Flutivate, Fexin, Momate, Candiderm, Others), Purchase Mode (OTC-Based, Prescription-Based), Application (Acne, Dermatitis, Psoriasis, Skin Infections, Hyperpigmentation, Melasma, Others), Medication Type (Ointments, Creams, Liquid & Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Potency Class (Ultra High, High, Moderate, Mild), End User (Hospital, Dermatology Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

The North America Topical Corticosteroids Market is expected to reach USD 1,992.97 million by 2024, from USD 1,284.08 million in 2016 growing at a CAGR of 5.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The factors such as increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market. On the other hand, expiry of patent for drugs, weak reimbursement policies, and stringent regulatory policies may hinder the growth of the market. The topical corticosteroids market in the North America region is leading in Japan.

Market Segmentation: North America Topical Corticosteroids Market 

  • The North America topical corticosteroids market is segmented on the basis of molecule name, brands, purchase mode, application, medication type, potency class, end user, distribution channel. On the basis of molecule name, North America topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others. In 2017, Fludroxycortide is expected to dominate the North America topical corticosteroids market with 26.6% market share and is expected to reach USD 579.03 million by 2024, growing at the highest CAGR of 7.0% in the forecast period 2017 to 2024.
  • On the basis of purchase mode, North America topical corticosteroids market is segmented into segmented into OTC-based and prescription-based. In 2017, prescription-based segment is expected to dominate the North America topical corticosteroids market with 72.1% market share and is expected to reach USD 1,468.23 million by 2024, growing at the highest CAGR of 6.0% in the forecast period 2017 to 2024.
  • The North America topical corticosteroids market, on the basis of brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
  • On the basis of application, North America topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, psoriasis segment is expected to dominate the North America topical corticosteroids market with 44.8% market share and is expected to reach USD 931.52 million by 2024, growing at the highest CAGR of 6.3% in the forecast period 2017 to 2024.
  • The North America topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments segment is expected to dominate the North America topical corticosteroids market with 33.1% market share and is expected to reach USD 639.40 million by 2024, growing at the highest CAGR of 5.2% in the forecast period 2017 to 2024. However, lotions segment is expected to grow at the highest CAGR of 6.9% in the forecast period, and is expected to reach USD 223.30 million in 2024 from USD 130.48 million in 2016.
  • The North America topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, moderate segment is expected to dominate the North America topical corticosteroids market with 40.2% market share and is expected to reach USD 834.43 million by 2024, growing at the highest CAGR of 6.3% in the forecast period 2017 to 2024.
  • The North America topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, a dermatology clinic segment is expected to dominate the North America topical corticosteroids market with 40.7% market share and is expected to reach USD 863.63 million by 2024, growing at the highest CAGR of 6.6% in the forecast period 2017 to 2024.
  • The North America topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, hospital pharmacies segment is expected to dominate the North America topical corticosteroids market with 46.3% market share and is expected to reach USD 958.63 million by 2024, growing at the highest CAGR of 6.2% in the forecast period 2017 to 2024.

Key Drivers: North America Topical Corticosteroids Market 

North America topical corticosteroids market is growing with the increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market.

Key Points: North America Topical Corticosteroids Market 

  • North America topical corticosteroids market is dominated by Merck & Co., Inc., followed by Pfizer Inc. and Glaxosmithkline Plc
  • Fludroxycortide segment is expected to dominate the North America topical corticosteroids market.
  • The topical corticosteroids market in the North America region is leading in U.S., Canada, and Mexico. U.S. accounts for the highest market share in this region.
Choose Licence Type

Enterprise, Single User

Available on Request

Available on Request.

Available on Request

Please fill in the below form and our sales representatives will get back to you soon

Please fill in the below form and our sales representatives will get back to you soon

`